Zynerba Pharmaceuticals

(NASDAQ: ZYNE)
Health Care  |  Pharmaceuticals
4.50 0.035 0.78%
Stock Price | Feb. 26, 2021, 4 p.m.
1 Follower
Bid:
Ask:
Prev. Close: 4.46
52 Week Low: 2.55
52 Week High: 9.0
PE Ratio:
Dividend Yield: %

Company Summary

Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates are ZYN001 and ZYN002. The company has initiated a clinical trial for both the product candidates.

Read more Read less

Recently Viewed Tickers

Premium An Urgent Market Update

66 Comments
3 months ago

Premium Cannabis Stocks Review - Pre-Market Edition 02/23/18

26 Comments
3 years ago

Premium Cannabis Stocks Review - AM Edition 02/21/18

23 Comments
3 years ago

Premium Cannabis Stocks Review - AM Edition 02/20/18

106 Comments
3 years ago

Premium Cannabis Stocks Review - Weekend Edition 02/20/18

113 Comments
3 years ago

Premium Cannabis Stocks Review - Pre-Market Edition 02/15/18

3 Comments
3 years ago

Premium Flying High Buy 02/14/18

50 Comments
3 years ago

Premium Cannabis Stocks Review - Weekend Edition 01/16/18

20 Comments
3 years ago

Premium Cannabis Stocks Review - AM Edition 01/10/18

31 Comments
3 years ago

Premium Cannabis Stocks Review - Pre-Market Edition 01/10/18

37 Comments
3 years ago